Overview

DEB-TACE+HAIC vs. HAIC for Large HCC

Status:
Recruiting
Trial end date:
2026-02-09
Target enrollment:
Participant gender:
Summary
This study is conducted to evaluate the efficacy and safety of transarterial chemoembolization with drug-eluting beads (DEB-TACE) plus hepatic artery infusion chemotherapy (HAIC) compared with HAIC alone for unresectable large hepatocellular carcinoma (HCC).
Phase:
Phase 3
Details
Lead Sponsor:
Second Affiliated Hospital of Guangzhou Medical University
Collaborators:
Affiliated Hospital of Guangdong Medical University
First Affiliated Hospital, Sun Yat-Sen University
First People's Hospital of Foshan
Hainan General Hospital
Jiangmen Central Hospital
Maoming People's Hospital
Zhongshan City People's Hospital